Sleep-HD trial: short and long-term effectiveness of existing insomnia therapies for patients undergoing hemodialysis

BACKGROUND: Patients with end-stage kidney disease (ESKD) treated with hemodialysis (HD) experience many distressing symptoms. One frequently reported symptom is insomnia. There are unique issues about HD treatments and schedules that disrupt regular sleep/wake routines and possibly contribute to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Unruh, Mark, Cukor, Daniel, Rue, Tessa, Abad, Kashif, Roumelioti, Maria-Eleni, McCurry, Susan M., Heagerty, Patrick, Mehrotra, Rajnish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574396/
https://www.ncbi.nlm.nih.gov/pubmed/33081705
http://dx.doi.org/10.1186/s12882-020-02107-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574396/
https://www.ncbi.nlm.nih.gov/pubmed/33081705
http://dx.doi.org/10.1186/s12882-020-02107-x

Ejemplares similares